1
|
Bucci LM, Lamprianou S, Gesualdo F, Tozzi AE, Ghalayini T, Sahinovic I, Pal S. A social media intervention for communicating vaccine safety in low- and middle-income countries: protocol for a pilot study. Front Public Health 2023; 11:1248949. [PMID: 38145079 PMCID: PMC10748494 DOI: 10.3389/fpubh.2023.1248949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2023] [Accepted: 11/06/2023] [Indexed: 12/26/2023] Open
Abstract
Vaccine safety is a concern that continues to drive hesitancy and refusal in populations in low-and-middle income countries (LMICs). Communicating about vaccine safety is a strategy that can successfully change personal and community perceptions and behaviors toward vaccination. The COVID-19 infodemic emergency with the rapid rollout of new vaccines and new technology, demonstrated the need for good and effective vaccine safety communication. The Vaccine Safety Net (VSN), a WHO-led global network of websites that provide reliable information on vaccine safety offers the ideal environment for gathering web and social media analytics for measuring impact of vaccine safety messages. Its members work with a wide range of populations, in different geographic locations and at many levels including national, regional, and local. We propose to undertake a pilot study to evaluate the feasibility of implementing COVID-19 vaccine safety communications with VSN members working in LMICs and to assess the impact of communications on public knowledge, attitudes, and perceptions.
Collapse
Affiliation(s)
| | | | - Francesco Gesualdo
- Predictive and Preventive Research Unit, Bambino Gesù Children’s Hospital, Rome, Italy
| | - Alberto E. Tozzi
- Predictive and Preventive Research Unit, Bambino Gesù Children’s Hospital, Rome, Italy
| | - Tala Ghalayini
- Accenture Health and Public Service, London, United Kingdom
| | | | - Shanthi Pal
- World Health Organization, Geneva, Switzerland
| |
Collapse
|
2
|
Salmon DA, Dudley MZ, Brewer J, Shaw J, Schuh HB, Proveaux TM, Jamison AM, Forr A, Goryn M, Breiman RF, Orenstein WA, Kao LS, Josiah Willock R, Cantu M, Decea T, Mowson R, Tsubata K, Bucci LM, Lawler J, Watkins JD, Moore JW, Fugett JH, Fugal A, Tovar Y, Gay M, Cary AM, Vann I, Smith LB, Kan L, Mankel M, Beekun S, Smith V, Adams SD, Harvey SA, Orton PZ. Corrigendum: LetsTalkShots: personalized vaccine risk communication. Front Public Health 2023; 11:1311055. [PMID: 38026293 PMCID: PMC10643483 DOI: 10.3389/fpubh.2023.1311055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2023] [Accepted: 10/10/2023] [Indexed: 12/01/2023] Open
Abstract
[This corrects the article DOI: 10.3389/fpubh.2023.1195751.].
Collapse
Affiliation(s)
- Daniel A. Salmon
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
- Department of Health, Behavior, and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Matthew Z. Dudley
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Janesse Brewer
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Jana Shaw
- Department of Public Health and Preventive Medicine, State University of New York, Upstate Medical University, Syracuse, NY, United States
- Department of Pediatrics, State University of New York, Upstate Medical University, Syracuse, NY, United States
| | - Holly B. Schuh
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
| | - Tina M. Proveaux
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Amelia M. Jamison
- Department of Health, Behavior, and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Amanda Forr
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Michelle Goryn
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Robert F. Breiman
- Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States
| | - Walter A. Orenstein
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
| | | | - Robina Josiah Willock
- Department of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, GA, United States
| | - Michelle Cantu
- Department of Immunization, National Association of County and City Health Officials, Washington, DC, United States
| | - Tori Decea
- Department of Immunization, National Association of County and City Health Officials, Washington, DC, United States
| | - Robin Mowson
- Department of Immunization, National Association of County and City Health Officials, Washington, DC, United States
| | | | | | | | - James D. Watkins
- Williams County Combined Health District, Montpelier, OH, United States
| | - Jamie W. Moore
- Guilford County Division of Public Health, Greensboro, NC, United States
| | - James H. Fugett
- Guilford County Division of Public Health, Greensboro, NC, United States
| | - Adriele Fugal
- Monongalia County Health Department, Morgantown, WV, United States
| | - Yazmine Tovar
- Monongalia County Health Department, Morgantown, WV, United States
| | - Marie Gay
- Orange County Department of Health, Goshen, NY, United States
| | - Aleen M. Cary
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Iulia Vann
- Utah County Health Department, Provo, UT, United States
| | - Lee B. Smith
- Guilford County Division of Public Health, Greensboro, NC, United States
| | - Lilly Kan
- Department of Immunization, National Association of County and City Health Officials, Washington, DC, United States
| | - Magda Mankel
- Border Studies Program, Earlham College, Tucson, AZ, United States
| | - Sumayya Beekun
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
- Center for Indigenous Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Victoria Smith
- Williams County Combined Health District, Montpelier, OH, United States
| | | | - Steven A. Harvey
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Peter Z. Orton
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| |
Collapse
|
3
|
Salmon DA, Dudley MZ, Brewer J, Shaw J, Schuh HB, Proveaux TM, Jamison AM, Forr A, Goryn M, Breiman RF, Orenstein WA, Kao LS, Josiah Willock R, Cantu M, Decea T, Mowson R, Tsubata K, Bucci LM, Lawler J, Watkins JD, Moore JW, Fugett JH, Fugal A, Tovar Y, Gay M, Cary AM, Vann I, Smith LB, Kan L, Mankel M, Beekun S, Smith V, Adams SD, Harvey SA, Orton PZ. LetsTalkShots: personalized vaccine risk communication. Front Public Health 2023; 11:1195751. [PMID: 37457264 PMCID: PMC10348877 DOI: 10.3389/fpubh.2023.1195751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Accepted: 06/12/2023] [Indexed: 07/18/2023] Open
Abstract
Introduction Vaccine hesitancy is a global health threat undermining control of many vaccine-preventable diseases. Patient-level education has largely been ineffective in reducing vaccine concerns and increasing vaccine uptake. We built and evaluated a personalized vaccine risk communication website called LetsTalkShots in English, Spanish and French (Canadian) for vaccines across the lifespan. LetsTalkShots tailors lived experiences, credible sources and informational animations to disseminate the right message from the right messenger to the right person, applying a broad range of behavioral theories. Methods We used mixed-methods research to test our animation and some aspects of credible sources and personal narratives. We conducted 67 discussion groups (n = 325 persons), stratified by race/ethnicity (African American, Hispanic, and White people) and population (e.g., parents, pregnant women, adolescents, younger adults, and older adults). Using a large Ipsos survey among English-speaking respondents (n = 2,272), we tested animations aligned with vaccine concerns and specific to population (e.g., parents of children, parents of adolescents, younger adults, older adults). Results Discussion groups provided robust feedback specific to each animation as well as areas for improvements across animations. Most respondents indicated that the information presented was interesting (85.5%), clear (96.0%), helpful (87.0%), and trustworthy (82.2%). Discussion Tailored vaccine risk communication can assist decision makers as they consider vaccination for themselves, their families, and their communities. LetsTalkShots presents a model for personalized communication in other areas of medicine and public health.
Collapse
Affiliation(s)
- Daniel A. Salmon
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
- Department of Health, Behavior, and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Matthew Z. Dudley
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Janesse Brewer
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Jana Shaw
- Department of Public Health and Preventive Medicine, State University of New York, Upstate Medical University, Syracuse, NY, United States
- Department of Pediatrics, State University of New York, Upstate Medical University, Syracuse, NY, United States
| | - Holly B. Schuh
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
| | - Tina M. Proveaux
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Amelia M. Jamison
- Department of Health, Behavior, and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Amanda Forr
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Michelle Goryn
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Robert F. Breiman
- Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States
| | - Walter A. Orenstein
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
| | | | - Robina Josiah Willock
- Department of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, GA, United States
| | - Michelle Cantu
- Department of Immunization, National Association of County and City Health Officials, Washington, DC, United States
| | - Tori Decea
- Department of Immunization, National Association of County and City Health Officials, Washington, DC, United States
| | - Robin Mowson
- Department of Immunization, National Association of County and City Health Officials, Washington, DC, United States
| | | | | | | | - James D. Watkins
- Williams County Combined Health District, Montpelier, OH, United States
| | - Jamie W. Moore
- Guilford County Division of Public Health, Greensboro, NC, United States
| | - James H. Fugett
- Guilford County Division of Public Health, Greensboro, NC, United States
| | - Adriele Fugal
- Monongalia County Health Department, Morgantown, WV, United States
| | - Yazmine Tovar
- Monongalia County Health Department, Morgantown, WV, United States
| | - Marie Gay
- Orange County Department of Health, Goshen, NY, United States
| | - Aleen M. Cary
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Iulia Vann
- Utah County Health Department, Provo, UT, United States
| | - Lee B. Smith
- Guilford County Division of Public Health, Greensboro, NC, United States
| | - Lilly Kan
- Department of Immunization, National Association of County and City Health Officials, Washington, DC, United States
| | - Magda Mankel
- Border Studies Program, Earlham College, Tucson, AZ, United States
| | - Sumayya Beekun
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
- Center for Indigenous Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Victoria Smith
- Williams County Combined Health District, Montpelier, OH, United States
| | | | - Steven A. Harvey
- Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| | - Peter Z. Orton
- Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States
| |
Collapse
|
4
|
O'Doherty KC, Crann S, Bucci LM, Burgess MM, Chauhan A, Goldenberg MJ, McMurtry CM, White J, Willison DJ. Deliberation on Childhood Vaccination in Canada: Public Input on Ethical Trade-Offs in Vaccination Policy. AJOB Empir Bioeth 2021; 12:253-265. [PMID: 34328070 DOI: 10.1080/23294515.2021.1941416] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
BACKGROUND Policy decisions about childhood vaccination require consideration of multiple, sometimes conflicting, public health and ethical imperatives. Examples of these decisions are whether vaccination should be mandatory and, if so, whether to allow for non-medical exemptions. In this article we argue that these policy decisions go beyond typical public health mandates and therefore require democratic input. METHODS We report on the design, implementation, and results of a deliberative public forum convened over four days in Ontario, Canada, on the topic of childhood vaccination. RESULTS 25 participants completed all four days of deliberation and collectively developed 20 policy recommendations on issues relating to mandatory vaccinations and exemptions, communication about vaccines and vaccination, and AEFI (adverse events following immunization) compensation and reporting. Notable recommendations include unanimous support for mandatory childhood vaccination in Ontario, the need for broad educational communication about vaccination, and the development of a no-fault compensation scheme for AEFIs. There was persistent disagreement among deliberants about the form of exemptions from vaccination (conscience, religious beliefs) that should be permissible, as well as appropriate consequences if parents do not vaccinate their children. CONCLUSIONS We conclude that conducting deliberative democratic processes on topics that are polarizing and controversial is viable and should be further developed and implemented to support democratically legitimate and trustworthy policy about childhood vaccination.
Collapse
Affiliation(s)
| | - Sara Crann
- Department of Psychology, University of Guelph, Guelph, Ontario, Canada
| | - Lucie Marisa Bucci
- Immunize Canada, c/o Canadian Public Health Association, Ottawa, Ontario, Canada
| | - Michael M Burgess
- W. Maurice Young Centre for Applied Ethics, The University of British Columbia, Vancouver, British Columbia, Canada
| | - Apurv Chauhan
- Department of Psychology, University of Guelph, Guelph, Ontario, Canada
| | - Maya J Goldenberg
- Department of Philosophy, University of Guelph, Guelph, Ontario, Canada
| | - C Meghan McMurtry
- Department of Psychology, University of Guelph, Guelph, Ontario, Canada
| | - Jessica White
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - Donald J Willison
- Department of Psychology, University of Guelph, Guelph and Pediatric Chronic Pain Program, McMaster Children's Hospital, Hamilton, Ontario, Canada
| |
Collapse
|
5
|
Gerges S, Peter E, Bowles SK, Diamond S, Bucci LM, Resnick A, Taddio A. Pharmacists as vaccinators: An analysis of their experiences and perceptions of their new role. Hum Vaccin Immunother 2017; 14:471-477. [PMID: 29140749 DOI: 10.1080/21645515.2017.1403695] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Abstract
OBJECTIVES In 2012, Ontario pharmacists were granted immunization privileges to administer influenza vaccines to the public. This study explored the experiences and practices of pharmacist vaccinators and the impact of vaccination pain on their practice. METHODS Semi-structured interviews were conducted with 12 pharmacists in the Greater Toronto Area. Transcribed interview data were coded and analyzed via thematic analysis. KEY FINDINGS Data analysis revealed 4 main themes: 1) expanded scope of practice as an enhancement and challenge to relationships; 2) professional satisfaction and workload demands; 3) knowledge and attitudes regarding pain and fear; 4) practices regarding pain and fear management. Pharmacists reported satisfaction in their new role, despite the associated increased workload. Pharmacists felt that vaccination pain was not a key consideration when administering vaccines and that pain management was generally not necessary. Fear was identified as more important than pain and vaccinating children was challenging and time intensive. Pharmacists' main focus was on injection techniques in managing pain. CONCLUSION These findings suggest that pharmacists are accepting of their role as vaccinators but more research is needed to examine impact on workload and pharmacist knowledge and perceptions of injection-related pain and fear.
Collapse
Affiliation(s)
- Sandra Gerges
- a Sunnybrook Health Sciences Centre , Toronto , Ontario , Canada
| | - Elizabeth Peter
- b Lawrence S. Bloomberg Faculty of Nursing, University of Toronto , Toronto , Ontario , Canada
| | - Susan K Bowles
- c Nova Scotia Health Authority , Halifax , Nova Scotia , Canada
| | | | | | - Anne Resnick
- f Ontario College of Pharmacists , Toronto , Ontario , Canada
| | - Anna Taddio
- g Leslie Dan Faculty of Pharmacy , Univeristy of Toronto , Toronto , Ontario , Canada
| |
Collapse
|
6
|
Abstract
Pain and fear widely contribute to negative experiences for students during school-based immunizations. In this preliminary research, we used a pre-existing network of 50 schools across Canada that participated in a biannual national immunization poster competition for grade 6 students organized by Immunize Canada to survey principals, teachers and students about their experiences with immunization pain and fear, how they want to learn about managing pain and fear and opportunities to include this information in the process of immunization. Responses revealed that both pain and fear are relevant to the immunization experience and that education and interventions are welcome by students and school staff. This may lead to improved attitudes about immunization, as well as future compliance with recommended immunizations.
Collapse
Affiliation(s)
| | - Noni E MacDonald
- Faculty of Medicine, Dalhousie University, IWK Health Centre, Halifax, Nova Scotia
| | - Chandni Sondagar
- Immunize Canada, Canadian Public Health Association, Ottawa, Ontario
| | - Anna Taddio
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario
| |
Collapse
|
7
|
Bucci LM, Fazio VM. [Genetic therapy in oncology: ethical aspects]. Clin Ter 2001; 152:217-24. [PMID: 11725612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
Abstract
The more advanced oncologic therapies are directing toward new frontiers, on account of the remarkable undesirable effects of chemio- and radio-therapies. This new therapeutic experiences are of type biological (vaccines), or genic (substitution again genes with shutters meaning-tumoral). This therapies involve, to be effected, some ethical shrewdnesses: choice of the patient, the engineering modality of the genes, the transfer of the genes in cells of the exclusively somatic line, the elimination of the pathogenic risk of the vector virus, the obligatory use of sterile rooms, the attention to the administration of the drug, a legal issue of the judgment of notoriety.
Collapse
Affiliation(s)
- L M Bucci
- Dipartimento di Medicina Legale, Università di Genova, Roma, Italia
| | | |
Collapse
|